Target Name: OLFM1
NCBI ID: G10439
Other Name(s): AMY | Neuronal olfactomedin-related ER localized protein | OTTHUMP00000022527 | OlfA | pancortin 1 | Olfactomedin related ER localized protein | Neuroblastoma protein | neuroblastoma protein | Olfactomedin-1 | Olfactomedin 1, transcript variant 1 | neuronal olfactomedin-related ER localized protein | Noelin | NOE1 | NOELIN1 | NOE1_HUMAN | Noelin (isoform 1) | OLFM1 variant 1 | OTTHUMP00000022526 | olfactomedin related ER localized protein | olfactomedin 1 | Pancortin 1

OLFM1: A Potential Drug Target for Cancer

OLFM1 (short for OLF1-like molecule 1) is a protein that is expressed in various tissues throughout the body. It is characterized by its unique structure, which is similar to that of AMY (alpha-melanoma-derived factor), a protein that is known to play a role in skin cancer development.

OLFM1 is expressed in a variety of tissues, including the brain, heart, and gastrointestinal tract. It is also highly expressed in cancer tissues, which suggests that it may be a potential drug target for cancer treatment.

One of the key features of OLFM1 is its role in cell signaling. It is a transcription factor that is involved in the regulation of gene expression, and it has been shown to play a role in a variety of cellular processes, including cell growth, differentiation , and survival.

OLFM1 has also been shown to be involved in the development and progression of cancer. For example, studies have shown that OLFM1 is highly expressed in various types of cancer, and that it is associated with poor prognosis in cancer patients.

Despite these promising findings, much more research is needed about OLFM1. In particular, there is a need for more research on its role in cancer development and treatment.

One potential way to study OLFM1 is to use it as a drug target. By targeting OLFM1 with small molecules or other compounds, researchers may be able to inhibit its activity and prevent cancer from developing cancer. This could be a valuable tool for cancer treatment.

Another potential way to study OLFM1 is to use it as a biomarker. By analyzing the levels of OLFM1 in cancer tissues, researchers may be able to identify new biomarkers for cancer diagnosis and treatment. This could be a valuable tool for cancer researchers to use in their studies.

Overall, OLFM1 is a protein that is worth further research. By studying its role in cell signaling and cancer development, researchers may be able to identify new ways to treat cancer and improve the lives of cancer patients.

Protein Name: Olfactomedin 1

Functions: Contributes to the regulation of axonal growth in the embryonic and adult central nervous system by inhibiting interactions between RTN4R and LINGO1. Inhibits RTN4R-mediated axon growth cone collapse (By similarity). May play an important role in regulating the production of neural crest cells by the neural tube (By similarity). May be required for normal responses to olfactory stimuli (By similarity)

More Common Targets

OLFM2 | OLFM3 | OLFM4 | OLFML1 | OLFML2A | OLFML2B | OLFML3 | OLIG1 | OLIG2 | OLIG3 | Oligosaccharyltransferase complex | OLMALINC | OLR1 | OMA1 | OMD | OMG | OMP | Oncostatin-M Receptor | ONECUT1 | ONECUT2 | ONECUT3 | OOEP | OOSP1 | OOSP2 | OPA1 | OPA1-AS1 | OPA3 | OPALIN | OPCML | OPHN1 | Opioid receptor | OPLAH | OPN1LW | OPN1MW | OPN1MW3 | OPN1SW | OPN3 | OPN4 | OPN5 | OPRD1 | OPRK1 | OPRL1 | OPRM1 | OPRPN | OPTC | OPTN | OR10A2 | OR10A3 | OR10A4 | OR10A5 | OR10A6 | OR10A7 | OR10AA1P | OR10AB1P | OR10AC1 | OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P